RogerKStrairMD

Hematologic Oncology

chief of Hematologic Malignancies/Hematopoietic Stem Cell Transplantation at Rutgers Cancer Institute of New Jersey, Professor of medicine at Robert Wood Johnson Medical School.

Join to view full profile

Dr. Strair is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Strair's full profile

Already have an account?

Office
195 Little Albany St
Rm 3005
New Brunswick, NJ 08901
Phone+1 732-235-7298

Fax+1 732-235-6797
Is this information wrong?

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1984 - 1988
Brigham and Women's HospitalResidency, Internal Medicine, 1981 - 1984
Albert Einstein College of MedicineClass of 1981

Certifications & Licensure

NJ State Medical License 1994 - 2025
CT State Medical License 1989 - 1994
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2011-2014
Inside Jersey Magazine Top Doctors Castle Connolly, 2009-2014
Top Doctors: New York Metro Area Castle Connolly, 2007-2014
Inside Jersey Top Doctors for Cancer Castle Connolly, 2012, 2014
New York Magazine: Top Doctors Castle Connolly, 2009-2010, 2014
America's Top Doctors for Cancer Castle Connolly, 2010-2013
NJ.com Top Doctors Castle Connolly, 2009
Join now to see all

Clinical Trials

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder Start of enrollment: 1998 Dec 01
Terminated
Phase 1
Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients Start of enrollment: 2004 Mar 01
Unknown status
Phase 2
Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate Start of enrollment: 2003 Mar 01
Terminated
Phase 1
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor Start of enrollment: 2001 May 01
Completed
Phase 1
LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma Start of enrollment: 2005 Feb 01
Terminated
Not Applicable
Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease Start of enrollment: 2005 Jan 01
Terminated
Phase 1
Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer Start of enrollment: 2004 Aug 01
Terminated
Phase 2
Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer Start of enrollment: 2009 Feb 01
Terminated
Phase 2
Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome Start of enrollment: 2010 Mar 01
Terminated
Not Applicable
Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation Start of enrollment: 2009 Oct 01
Terminated
Phase 1
Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies Start of enrollment: 2011 Mar 01
Terminated
Phase 2
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
Recruiting
Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies Start of enrollment: 2014 Jan 01
Withdrawn
Phase 2
AML Therapy With Irradiated Allogeneic Cells Start of enrollment: 2014 Feb 01
Terminated
Not Applicable
Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia Start of enrollment: 2009 Jan 01
Completed
Phase 2
Lactobacillus Rhamnosus GG in Reducing Incidence of Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant Start of enrollment: 2013 Feb 18
Completed
Not Applicable
Romidepsin in Treating Patients With Steroid-Refractory Graft-versus-Host Disease Start of enrollment: 2014 Nov 01
Terminated
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cel...
Mary Elizabeth Percival, Hai-Lin Wang, Mei-Jie Zhang, Wael Saber, Marcos de Lima, Mark R. Litzow, Partow Kebriaei, Hisham Abdel-Azim, Kehinde Adekola, Mahmoud Aljurf, ...> ;Bone Marrow Transplantation. 2021 Sep 1
5 citations
Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation.
Mary-Elizabeth Percival, Hai-Lin Wang, Mei-Jie Zhang, Wael Saber, Marcos de Lima, Mark Litzow, Partow Kebriaei, Hisham Abdel-Azim, Kehinde Adekola, Mahmoud Aljurf, Ulr...> ;Bone Marrow Transplantation. 2021 Sep 1
8 citations
Incorporation of posttransplant cyclophosphamide as part of standard immunoprophylaxis for all allogeneic transplants: a retrospective, single institution study.
Dennis L. Cooper, Jacqueline Manago, Vimal Patel, Dale G. Schaar, Tracy Krimmel, Mary Kate McGrath, Anne Tyno, Yong Lin, Roger Strair> ;Bone Marrow Transplantation. 2021 May 1
2 citations
Incorporation of extracorporeal photopheresis into a reduced intensity conditioning regimen in myelodysplastic syndrome and aggressive lymphoma: results from ECOG 1402...
Francine M. Foss, Xin Victoria Wang, Selina M. Luger, Opeyemi Jegede, Kenneth B. Miller, Edward A. Stadtmauer, Theresa L. Whiteside, David Avigan, Randall D. Gascoyne,...> ;Transfusion. 2020 Jul 12
32 citations
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.
Annie Im, Armin Rashidi, Tao Wang, Michael T. Hemmer, Margaret L. MacMillan, Joseph Pidala, Madan Jagasia, Steven Z. Pavletic, Navneet S. Majhail, Daniel J. Weisdorf, ...> ;Biology of Blood and Marrow Transplantation. 2019 Mar 1
32 citations
A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-cell Lymphoma
Victor Yazbeck, Danielle Shafer, Edward B. Perkins, Domenico Coppola, Lubomir Sokol, Kristy L. Richards, Thomas B. Shea, Jia Ruan, Samir Parekh, Roger Strair, Christop...> ;Clinical Lymphoma, Myeloma & Leukemia. 2011 Nov 18
1 citations
Bad Blood or Sick Patient
Ramy Sedhom, Roger Strair, Jeffrey L. Carson> ;Biology of Blood and Marrow Transplantation. 2018 May 1
Universal Health Care: The Cost of Being Human.
Strair, R., Strair, R.> ;The Journal of clinical ethics.
The enteric toxicity of gluten enhances graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Neuman, T.,David, K.,Cooper, D.,Strair, R.> ;Med. Hypotheses. 2017 Jul 05
4 citations
Choline-magnesium trisalicylate modulates acute myelogenous leukemia gene expression during induction chemotherapy
Daniel J. Medina, Kevin A. David, Yong Lin, Dale G. Schaar, Vimal Patel, Mecide Gharibo, Rajat Bannerji, Kelly Walton, Joseph Aisner, Arnold B. Rabson, Roger Strair> ;Leukemia & Lymphoma. 2017 May 4
45 citations
Lactobacillus rhamnosus GG probiotic enteric regimen does not appreciably alter the gut microbiome or provide protection against GVHD after allogeneic hematopoietic st...
Elan Gorshein, Catherine Wei, Susan Ambrosy, Shanna Budney, Juliana Vivas, Angelika Shenkerman, Jacqueline Manago, Mary Kate McGrath, Anne Tyno, Yong Lin, Vimal Patel,...> ;Clinical Transplantation. 2017 May 1
227 citations
Results of the phase i trial of RG7112, a small-molecule MDM2 antagonist in leukemia
Michael Andreeff, Kevin R. Kelly, Karen W.L. Yee, Sarit Assouline, Roger Strair, Leslie Popplewell, David G. Bowen, Giovanni Martinelli, Mark Drummond, Paresh Vyas, Ma...> ;Clinical Cancer Research. 2016 Feb 15
11 citations
Transfusion strategies in hematologic and nonhematologic disease
Jeffrey L. Carson, Roger Strair> ;Hematology. American Society of Hematology. Education Program. 2014 Dec 5
15 citations
Cobblestone-Area Forming Cells Derived from Patients with Mantle Cell Lymphoma Are Enriched for CD133+ Tumor-Initiating Cells
Daniel J. Medina, Jeneba Abass-Shereef, Kelly Walton, Lauri Goodell, Hana Aviv, Roger Strair, Tulin Budak-Alpdogan> ;Plos One. 2014 Apr 10
2 citations
Haemophagocytic lymphohistiocytosis and primary central nervous system lymphoma.
Saurabh Chhabra, Roger Strair, A. Rubin> ;Internal Medicine Journal. 2013 Apr 1
3 citations
Duplication of chromosome 1 [dup(1)(q21q32)] as the sole cytogenetic abnormality in a patient previously treated for AML
Douglas F. Beach, Barry L. Barnoski, Hana Aviv, Vimal Patel, Roland Schwarting, Roger Strair, Neil A. Lachant> ;Cancer Genetics. 2012 Dec 1
2 citations
Irradiated allogeneic cells enhance umbilical cord blood stem cell engraftment in immunodeficient mice
Tulin Budak-Alpdogan, G. Jeganathan, Kuo-Chieh Lee, Zbigniew R. Mrowiec, Daniel J. Medina, Dennis Todd, Dirk F. Moore, Joseph R. Bertino, Roger K. Strair> ;Bone Marrow Transplantation. 2012 May 21
65 citations
Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B-cell activating factor and activation o...
Daniel J. Medina, Lauri Goodell, John Glod, Céline Gélinas, Arnold B. Rabson, Roger Strair> ;Haematologica. 2012 Aug 1
Pharmacokinetics (PK) and pharmacodynamics (PD) of RG7112, an oral murine double minute 2 (MDM2) antagonist, in patients with leukemias and solid tumors.
Beryozkina A, Nichols GL, Reckner M, Vassilev LT, Rueger R, Jukofsky L, Middleton S, Andreeff M, Padmanabhan S, Strair R, Delioukina ML, Maslak PG, Hillmen P, Kurzrock...> ;J. Clin. Oncol.. 2011-05-20
61 citations
Differentiation-associated miR-22 represses Max expression and inhibits cell cycle progression.
Yi Ting, Daniel J. Medina, Roger K. Strair, Dale G. Schaar> ;Biochemical and Biophysical Research Communications. 2010 Apr 9
2 citations
Accelerated R-COP: a pilot study for the treatment of advanced low grade lymphomas that has a high complete response rate.
M.J. Levitt, Mecide Gharibo, Roger Strair, Dale G. Schaar, A. Rubin, Joseph R. Bertino> ;Journal of Chemotherapy. 2009 Aug 1
109 citations
miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation.
Dale G. Schaar, Daniel J. Medina, Dirk F. Moore, Roger K. Strair, Yi Ting> ;Experimental Hematology. 2009 Feb 1
13 citations
A pilot study of allogeneic cellular therapy for patients with advanced hematologic malignancies.
Daniel J. Medina, Mecide Gharibo, Philip Savage, Alan Cohler, Mercy Kuriyan, Binaifer Balsara, Monika Anand, Dale G. Schaar, Tracy Krimmel, Kara Saggiomo, Jacqueline M...> ;Leukemia Research. 2008 Dec 1
13 citations
Nuclear Factor-κB Modulation in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia
Roger K. Strair, Mecide Gharibo, Dale G. Schaar, A. Rubin, Jonathan S. Harrison, Joseph Aisner, Hsin-Ching Lin, Yong Lin, Lauri Goodell, Monika Anand, Binaifer Balsara...> ;Clinical Cancer Research. 2008 Nov 15
179 citations
A Phase 2 Clinical Trial of Deforolimus (AP23573, MK-8669), a Novel Mammalian Target of Rapamycin Inhibitor, in Patients with Relapsed or Refractory Hematologic Malign...
David A. Rizzieri, Eric J. Feldman, John F. DiPersio, Nashat Gabrail, Wendy Stock, Roger Strair, Victor M. Rivera, Maher Albitar, Camille L. Bedrosian, Francis J. Giles> ;Clinical Cancer Research. 2008 May 1
Join now to see all

Press Mentions

Breast Cancer Awareness MonthOctober 7th, 2022
Small Mutations Identified Through Deep DNA Sequencing for AML and MDSDecember 9th, 2019
Physicians at Rutgers Cancer Institute of New Jersey Named as ‘Jersey Choice Top Doctors’October 31st, 2017
Join now to see all

Grant Support

Phase I Trial Of 12 0 Tetradecanoylphorbol 13 AcetateNational Cancer Institute2000–2001
Detection Of Viral Transaction In Primary CellsNational Cancer Institute1993
Detection Of Viral Transactivators In Primary CellsNational Cancer Institute1991–1993
Isolation Of A Human E1a-Like FactorNational Cancer Institute1989–1993
Isolation Of A Human E1a-Like FactorNational Cancer Institute1989